Medialis has supported clients promoting a medicines for the treatment of type 2 diabetes, XLH, cancer, cardiac and neurological disorders and a variety of rare diseases
Currently, influenza vaccine manufacturing using embryonated hen’s eggs remains the most common vaccine production method, primarily due to historical factors, the availability of supply, and lower costs.
Medialis devised a method to construct the ‘optimal’ characteristics of a GLP-1 given a range of characteristics from real products.
Three meta-analyses were conducted, which showed that in terms of efficacy, the three members were indeed equivalent, approved for treating of EGFR+ve non small cell lung cancer
Medialis carried out full training for the sales force and implemented 1:1 online briefings for key customers. An electronic and paper leave pieces were also produced.